-
Emergent to develop anthrax vaccine on HHS' behalf
WASHINGTON Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority to develop a new anthrax vaccine.
In the first two years of the contract, Emergent will develop the final vaccine formulation and test its stability. HHS said it can extend the contract annually for up to three years to support scale-up and optimization for large-scale manufacturing, as well as additional animal studies needed to apply for Food and Drug Administration approval of the vaccine.
-
Indie Candy keeps Halloween treats natural, allergen-free
BIRMINGHAM, Ala. Parents looking to take the fright out of shopping for Halloween candy can look no further than Indie Candy, a maker of all-natural, allergen-free candy.
All of Indie Candy's products are created in a facility free of wheat/gluten, casein/dairy, tree nuts, peanuts, shellfish, fish, soy and eggs, the company said. Indie Candy offers such Halloween candy as: